BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25238893)

  • 1. Advanced therapeutic directions to treat the underactive bladder.
    Smith PP; Tyagi P; Kuchel GA; Pore S; Chermansky C; Chancellor M; Yoshimura N; Levanovich P
    Int Urol Nephrol; 2014 Sep; 46 Suppl 1():S35-44. PubMed ID: 25238893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underactive Bladder in Older Adults.
    Chuang YC; Plata M; Lamb LE; Chancellor MB
    Clin Geriatr Med; 2015 Nov; 31(4):523-33. PubMed ID: 26476113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underactive bladder in women: is there any evidence?
    Cohn JA; Brown ET; Kaufman MR; Dmochowski RR; Reynolds WS
    Curr Opin Urol; 2016 Jul; 26(4):309-14. PubMed ID: 26927630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives.
    Wang J; Ren L; Liu X; Liu J; Ling Q
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatments available for the management of underactive bladder in neurological conditions.
    Ladi-Seyedian SS; Nabavizadeh B; Sharifi-Rad L; Kajbafzadeh AM
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):193-204. PubMed ID: 29202586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The other bladder syndrome: underactive bladder.
    Miyazato M; Yoshimura N; Chancellor MB
    Rev Urol; 2013; 15(1):11-22. PubMed ID: 23671401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underactive Bladder.
    Aggarwal H; Zimmern PE
    Curr Urol Rep; 2016 Mar; 17(3):17. PubMed ID: 26874529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study in the USA of the epidemiology and quality of life of underactive bladder symptoms.
    Faraj K; Doo F; Boura J; Vereecke A; Chancellor MB
    Int Urol Nephrol; 2016 Nov; 48(11):1797-1802. PubMed ID: 27473156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detrusor underactivity and the underactive bladder: Symptoms, function, cause-what do we mean? ICI-RS think tank 2014.
    Smith PP; Birder LA; Abrams P; Wein AJ; Chapple CR
    Neurourol Urodyn; 2016 Feb; 35(2):312-7. PubMed ID: 26872574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and demographics of the underactive bladder: a cross-sectional survey.
    Valente S; DuBeau C; Chancellor D; Okonski J; Vereecke A; Doo F; Lajiness M; Diokno A; Chancellor M
    Int Urol Nephrol; 2014 Sep; 46 Suppl 1():S7-10. PubMed ID: 25238889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates of underactive bladder: a review of the recent literature.
    Li X; Liao L
    Int Urol Nephrol; 2016 Jun; 48(6):919-30. PubMed ID: 26931421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case for pharmacotherapy development for underactive bladder.
    Chancellor MB; Kaufman J
    Urology; 2008 Nov; 72(5):966-7. PubMed ID: 18774593
    [No Abstract]   [Full Text] [Related]  

  • 13. Qualitative Exploration of the Patient Experience of Underactive Bladder.
    Uren AD; Cotterill N; Harding C; Hillary C; Chapple C; Klaver M; Bongaerts D; Hakimi Z; Abrams P
    Eur Urol; 2017 Sep; 72(3):402-407. PubMed ID: 28400168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity.
    Harada T; Fushimi K; Kato A; Ito Y; Nishijima S; Sugaya K; Yamada S
    Biol Pharm Bull; 2010; 33(4):653-8. PubMed ID: 20410601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and animal modeling of underactive bladder.
    Tyagi P; Smith PP; Kuchel GA; de Groat WC; Birder LA; Chermansky CJ; Adam RM; Tse V; Chancellor MB; Yoshimura N
    Int Urol Nephrol; 2014 Sep; 46 Suppl 1(0 1):S11-21. PubMed ID: 25238890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underactive bladder, detrusor underactivity, definition, symptoms, epidemiology, etiopathogenesis, and risk factors.
    Aldamanhori R; Chapple CR
    Curr Opin Urol; 2017 May; 27(3):293-299. PubMed ID: 28221218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing incontinence due to detrusor instability.
    Drug Ther Bull; 2001 Aug; 39(8):59-64. PubMed ID: 11526802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New technology assessment and current and upcoming therapies for underactive bladder.
    Chancellor MB; Bartolone SN; DeVries EM; Diokno AC; Gibbons M; Jankowski R; Lamb LE; Pruchnic R; Thor K; Dmochowski R
    Neurourol Urodyn; 2018 Nov; 37(8):2932-2937. PubMed ID: 29953660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallizing the Definition of Underactive Bladder Syndrome, a Common but Under-recognized Clinical Entity.
    Chapple CR; Osman NI
    Low Urin Tract Symptoms; 2015 May; 7(2):71-6. PubMed ID: 26663685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining and advancing education and conservative therapies of underactive bladder.
    Griebling TL; DuBeau CE; Kuchel G; Wilde MH; Lajiness M; Tomoe H; Diokno A; Vereecke A; Chancellor MB
    Int Urol Nephrol; 2014 Sep; 46 Suppl 1():S29-34. PubMed ID: 25238892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.